03-23-2008, 12:51 PM
|
|
Reader
|
� |
Join Date: Apr 2006
Location: Propecia, CA
Posts: 1,852
|
|
Ecklonia Cava Extract (ECE)
Quote:
Summary of ECE
• Uniquely strong antioxidant scavenging of lipids, calcium, iron, and cholesterol as well as "free radicals" from the cardiovascular system (thereby lowering risk of stroke and cardiovascular events, lowering cholesterol levels, and reducing vasculitis-associated neuropathy)
• Strong anti-plasmin inhibition effect (i.e., enhances blood flow, thereby lowering blood pressure and increasing arterial blood flow)
• Strong elastase agonist effect, thereby increasing the flexibility of the vascular system and helping normalize blood flows and blood pressure
• Significant anti-inflammatory effect, by inhibition of the Nf-kB inflammatory pathway, which also serves to normalize blood glucose levels and lead to statistically-significant re-establishment of insulin sensitivity in the pancreas
• Downregulation (by 60%) of the DGAT enzyme responsible for lipid (fat) metabolism, thereby assisting in fat/weight loss
• Significant analgesic effect in inhibiting the expression of the COX enzymes for arthritis, as well as for neuropathic and FMS/CFS pain
• Inhibition of beta-amyloid brain plaque formation as well as short-term memory in mammals, thereby improving overall memory function
• Anti-tumor effects (currently tested only for dermatologic cancers in mice)
Summary of Clinical Studies
• Hypertensive cardiovascular patients (reduction of blood pressure and increase of brachial artery FMD [+43%] and NMD [+59%] in CAD patients [11 of 39 patients, the others being healthy normals]
• Analgesia in osteoarthritic patients (comparable to the COX-2 inhibitors)
• Weight loss in both obese and normal patients
• Erectile dysfunction on males with ED (comparable to Viagra�)
• Analgesia in neuropathic pain patients (i.e., neuralgia)
• Major multi-symptom management (i.e., reduction in pain, fatigue, sleep disorders) for fibromyalgia patients.
|
https://www.townsendletter.com/FebMar...eranti0208.htm
|